Conversely, RB1 altered expression seems to be predictive of nonresponse to intravesical bacille Calmette-Guerin (BCG) +/− IFN-α treatment and tumor recurrence in bladder cancer patients [113, 114]. The gene discussed is RB1; the disease is urinary bladder carcinoma.